Here comes the embryonic stem cell debate again. It?s time to get past this recurring hurdle to ethical and enormously promising medical research. Millions of patients with debilitating diseases will have much better shots at improved treatments – maybe even cures – if embryonic stem cell research is allowed to continue in Madison and elsewhere using federal dollars.
Office of Strategic Communication